Scientific Reports (Feb 2024)

Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level

  • Anna Perkiö,
  • Barun Pradhan,
  • Fatih Genc,
  • Anna Pirttikoski,
  • Sanna Pikkusaari,
  • Erdogan Pekcan Erkan,
  • Matias Marin Falco,
  • Kaisa Huhtinen,
  • Sara Narva,
  • Johanna Hynninen,
  • Liisa Kauppi,
  • Anna Vähärautio

DOI
https://doi.org/10.1038/s41598-024-54113-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Long interspersed nuclear elements (LINE-1s/L1s) are a group of retrotransposons that can copy themselves within a genome. In humans, it is the most successful transposon in nucleotide content. L1 expression is generally mild in normal human tissues, but the activity has been shown to increase significantly in many cancers. Few studies have examined L1 expression at single-cell resolution, thus it is undetermined whether L1 reactivation occurs solely in malignant cells within tumors. One of the cancer types with frequent L1 activity is high-grade serous ovarian carcinoma (HGSOC). Here, we identified locus-specific L1 expression with 3′ single-cell RNA sequencing in pre- and post-chemotherapy HGSOC sample pairs from 11 patients, and in fallopian tube samples from five healthy women. Although L1 expression quantification with the chosen technique was challenging due to the repetitive nature of the element, we found evidence of L1 expression primarily in cancer cells, but also in other cell types, e.g. cancer-associated fibroblasts. The expression levels were similar in samples taken before and after neoadjuvant chemotherapy, indicating that L1 transcriptional activity was unaffected by clinical platinum-taxane treatment. Furthermore, L1 activity was negatively associated with the expression of MYC target genes, a finding that supports earlier literature of MYC being an L1 suppressor.